Dharwad Dist Hosp gets chemotherapy centre
The chemotherapy centre has been set up in association with HCG Hospital, Hubballi, under AB-ArK (Ayushman Bharat-Arogya Karnataka) scheme, he said.
Tired of too many ads? go ad free now
For every patient who has undergone the 1st cycle of treatment, the next cycle will be treated as per the advice of an oncologist. Every Wednesday, the patients will be examined by a cancer specialist at the hospital. Getting treatment here will benefit the patients from distant places, Lad said. A total of 242 patients have been sent for cancer treatment from the hospital in 2024-2025.
District surgeon Dr Sangappa Gabi, resident medical officer Dr Girijatai GH, senior specialists Dr Mayura Kadam and Dr SM Sambrani, nursing superintendent Vijayakumar Malagi, office superintendent VH Banasode and other staff were present.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
2 hours ago
- Business Standard
Max, Aster DM, Apollo rally up to 7%; what's driving hospital stocks today?
Hospital stocks in focus: Shares of the listed companies engaged in hospital business like Max Healthcare Institute, Aster DM Healthcare and Apollo Hospitals Enterprise have rallied up to 7 per cent, hitting their respective new highs on the BSE in Thursday's intra-day trade on healthy business outlook. Among the individual stocks, Aster DM Healthcare has surged 7 per cent to ₹638.60, on the back of a 20-fold jump in average trading volumes. A combined 16.06 million equity shares representing 3.2 per cent of total equity of the company have changed hands on the NSE and BSE. Shares of Apollo Hospitals Enterprise (₹7,599.75) and Max Healthcare Institute (₹1,308.55) were up 2 per cent on the BSE. Besides these three stocks, Global Health, Fortis Healthcare, Fortis Malar Hospitals, Narayana Hrudayalaya and Yatharth Hospital & Trauma Care Services were up in the range of 1 per cent to 3 per cent. In comparison, the BSE Sensex was up 0.18 per cent at 83,562 at 02:07 PM. What's driving hospital stocks? According to CRISIL MI&A Research, the Indian healthcare delivery industry is projected to experience major growth, with a compound annual growth rate (CAGR) of 9-11 per cent anticipated between fiscal years 2025 and 2027. This growth trajectory is underpinned by several long term structural factors, including rising healthcare needs due to demographic shifts and increasing chronic disease prevalence. Additionally, the industry's strong fundamentals, coupled with improving affordability among the population, are expected to drive demand for healthcare services. Furthermore, the potential impact of initiatives such as the Ayushman Bharat scheme, aimed at providing universal health coverage, is poised to further propel industry growth during this period. With sustained support from long-term structural factors, renewed emphasis on the Pradhan Mantri Jan Arogya Yojana (PMJAY), and heightened Government focus on the healthcare sector, the healthcare delivery market is projected to expand at a CAGR of approximately 9-11 per cent, reaching ₹8.6 trillion by fiscal 2027, Apollo Hospital said in its annual report. Given the major mismatch between demand and supply for quality beds, along with the improved financial health of corporate hospitals following the pandemic, players appear well-positioned to achieve profitable growth as they strengthen their presence in core markets and venture into Tier 2+ areas geographies, CareEdge Ratings said. CareEdge Ratings forecasts that the corporate hospital chains in its coverage will achieve approximately 10-12 per cent year-on-year sales growth in fiscal 2026, driven by a 5-6 per cent increase in Average Revenue Per Occupied Bed (ARPOB), a 100-200 basis point (bps) improvement in occupancy, and rise in new bed additions. With significant untapped market opportunities and a shortage of healthcare infrastructure in India, leading Indian companies have immense potential for expansion. Supported by long-term structural growth factors, renewed momentum from PMJAY, and increased government focus on the healthcare sector, the Indian hospital sector is projected to grow at a CAGR of 10-11 per cent over the next 3-5 years. Key demand drivers include the rise in lifestyle-related diseases, growing medical tourism, increasing incomes, and demographic changes. With limited government capital expenditure and a lack of infrastructure, the private sector is expected to experience accelerated growth in the years to come, CareEdge Ratings said in its March 2025 report.
Indian Express
11 hours ago
- Indian Express
Fake Dr John Camm case exposed police failures, NHRC says
In its report on the case of a fake cardiologist, who practised in Madhya Pradesh and other parts of India after falsely taking the identity of UK-based Dr N John Camm, the National Human Rights Commission (NHRC) has criticised the police investigation, finding 'several discrepancies' and inadequate charges filed against those responsible for seven patient deaths. The NHRC report, submitted on July 1, said: 'The present case is connected with deaths of victims during treatment provided by the alleged fake doctors. The police have registered the FIR under sections of IPC which prescribe much lesser punishment, whereas allegations pertain to homicide, cheating, forgery etc.' The accused, Narendra Vikramaditya Yadav, was later arrested from Uttar Pradesh in April and is currently under judicial custody. The NHRC criticised the police investigation, saying that 'the police failed to take cognisance of the fact that the present FIR pertains to treatment given by a fake doctor, not medical negligence. The police should have initiated the investigation rather to wait for the inquiry report.' The commission said, 'The submission of questionable documents, absence of a verifiable qualification/license and permitting an unqualified person to not only practise as a doctor but also to perform life-threatening critical surgeries are wilful negligence and severe breach of statutory duties by CMHO, Damoh (the Chief Medical and Health Officer of Madhya Pradesh's Damoh district).' The report revealed that Yadav had falsely claimed to be an alumnus of North Bengal Medical College, and that the institution had denied this claim. The NHRC report also alleged that the management of the Damoh hospital where he worked had engaged in fraudulent activities for years without proper oversight. 'The accused was running the hospital since several years. However, it is evident that no effort was taken by the CMHO, Damoh, to verify the degree and registration of the doctors and the establishment. Apparently, no inspection was carried out prior to the filing of the present complaint,' the report said. The hospital also allegedly misused the credentials of another doctor, Dr Akhilesh Dubey, to fraudulently obtain a license for its Cath Lab without his consent, the report said. According to the commission's findings, 'Dr Akhilesh Dubey informed that he had been providing Super Specialist OPD at Mission Hospital, Damoh, once in a month for the last 3 to 5 years and Mission Hospital runs a Cath Lab at Damoh. However, he has no relation with the Cath Lab of Mission Hospital.' The report also alleged serious irregularities in the implementation of the Ayushman Bharat government-sponsored health insurance scheme at the hospital. It said the hospital 'systematically misused the scheme by issuing fraudulent bills for treatments'. Families of patients were allegedly compelled to pay substantial amounts despite having Ayushman Bharat cards. The report said, 'In several cases, patient was allegedly compelled to pay Rs 2,15,000 (to) Rs 2,80,000 for an angiography and other procedures, and even the Ayushman Bharat card was taken at the time of admission, however, no money or very less money was refunded back to the family members.' The NHRC has directed the Madhya Pradesh government to file separate FIRs and provide compensation to the families of those who died allegedly after being treated by the fake cardiologist.
Time of India
13 hours ago
- Time of India
Surgeons rebuild man's penis in rare, 9.5 hour operation
Nagpur: In a rare medical feat, surgeons at Lata Mangeshkar Hospital successfully rebuilt the penis of a young man from Rajasthan, who lost the organ to cancer eight years ago. The complex operation, lasting 9.5 hours, is believed to be the first of its kind performed in a single stage in Central India. "The patient was living without a penis for several years. Reconstructing the organ restored not just physical function but also his confidence and dignity," said Dr Jitendra Mehta, one of the lead plastic surgeons on the case. To reconstruct the penis, doctors first created the shape of the shaft and urinary passage (urethra) using tissue from the patient's forearm. This tissue was then surgically transplanted to the groin area. Crucially, the surgical team connected tiny blood vessels under a microscope — a procedure known as microvascular surgery — to ensure proper blood supply. Nerves were also attached to help restore sensation. "Such surgeries demand immense precision. We work under a microscope to join vessels thinner than a matchstick," explained Dr Sameer Mahakalkar, another plastic surgeon involved. "It's meticulous work, but it gives patients a chance to lead a normal life. " While this operation was performed due to cancer-related loss, similar techniques can help men injured in accidents or those undergoing gender-affirmation surgery. Dr Sajal Mitra, dean of NKP Salve Institute of Medical Sciences and Research Centre, praised the surgical team's dedication. "This is not just a surgical success — it's a step forward for reconstructive medicine in our region. Such cases remind us why training, teamwork, and technology are so vital. " The surgical team included Dr Mehta, Dr Mahakalkar, Dr Ashwini Panditrao, Dr Dev Patel, Dr Abhiram Mundle, Dr Kanwarbir, and Dr Pallavi. Anaesthesia support was provided by Dr Anjali Bhure, Dr Madhushree Shah, Dr Ketaki Marodkar, and Dr Rachana Naitam. Dr Nitin Deosthale, medical superintendent and vice dean, coordinated logistics. Hospital officials confirmed the patient is recovering well and will soon be able to pass urine normally through the reconstructed organ. Such procedures are performed free of cost under govt health schemes like Ayushman Bharat and Mahatma Jyotiba Phule Jan Aarogya Yojana, helping patients who might otherwise be unable to afford advanced surgeries. "This is a life-changing operation," said Dr Mehta. "It's about restoring hope." Recreating Manhood *Tissue Taken from Forearm: Doctors shaped skin and tissue from the patient's forearm to build new penis *Urethra Created Inside: Tube to pass urine (urethra) was crafted inside reconstructed organ *Transplanted to Groin Area: New organ carefully attached to groin region *Tiny Blood Vessels Joined: Surgeons used microscope to connect small blood vessels for blood supply *Nerves Connected for Sensation: Nerves were joined to help restore feeling and function in the new organ
